Inhaled tigecycline is effective against Mycobacterium abscessus in vitro and in vivo

BACKGROUND: Mycobacterium abscessus causes chronic pulmonary infections. Owing to its resistance to most classes of antibiotics, treatment is complex and cure rates are only 45%. Tigecycline is active against M. abscessus, but severe toxicity and the need for IV administration limit its use. OBJECTI...

Descripción completa

Detalles Bibliográficos
Autores principales: Pearce, Camron, Ruth, Mike M, Pennings, Lian J, Wertheim, Heiman F L, Walz, Amanda, Hoefsloot, Wouter, Ruesen, Carolien, Muñoz Gutiérrez, Juan, Gonzalez-Juarrero, Mercedes, van Ingen, Jakko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778363/
https://www.ncbi.nlm.nih.gov/pubmed/32294173
http://dx.doi.org/10.1093/jac/dkaa110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778363/
https://www.ncbi.nlm.nih.gov/pubmed/32294173
http://dx.doi.org/10.1093/jac/dkaa110

Ejemplares similares